Comprehensive medication guide to Drizalma Sprinkle including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$30–$75 copay typical with insurance coverage (Tier 3 on most plans); prior authorization required to document medical necessity of the sprinkle formulation. Step therapy to generic duloxetine capsules may apply before approval.
Estimated Cash Pricing
$226–$273 retail for a 30-day supply (all strengths similarly priced); as low as $225 with a GoodRx coupon or $104–$225 with SingleCare depending on pharmacy and strength. No FDA-approved generic version exists for this specific sprinkle formulation.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Drizalma Sprinkle is the brand name for duloxetine delayed-release sprinkle capsules, manufactured by Sun Pharmaceutical Industries. It belongs to the SNRI (serotonin-norepinephrine reuptake inhibitor) drug class and is used to treat major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain.
What makes Drizalma Sprinkle unique is its formulation: the delayed-release capsule can be opened and the pellets inside sprinkled onto a tablespoon of applesauce, then swallowed immediately. It can also be administered via nasogastric tube. This makes it the only duloxetine option specifically designed for patients who cannot swallow whole capsules — including children aged 7+ with anxiety disorders, elderly patients with dysphagia, and tube-fed patients.
Drizalma Sprinkle is available in 20 mg, 30 mg, 40 mg, and 60 mg delayed-release sprinkle capsules. As of 2026, there is no FDA-approved generic version of this specific sprinkle-capsule formulation, making it a brand-name-only product manufactured by a single company.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Drizalma Sprinkle (duloxetine) works by blocking the reuptake of two neurotransmitters — serotonin and norepinephrine — in the synapses between nerve cells in the brain and spinal cord. By preventing these chemicals from being reabsorbed too quickly, duloxetine increases their availability and sustained activity, which improves communication between neurons involved in mood regulation, anxiety, and pain processing.
The serotonin component primarily helps regulate mood, anxiety, and emotional stability, which is why duloxetine is effective for depression and anxiety disorders. The norepinephrine component strengthens the descending pain inhibition pathways in the spinal cord — natural circuits that reduce pain signals traveling from the body to the brain. This dual action makes duloxetine one of the few antidepressants with FDA-approved indications for both psychiatric conditions and chronic pain disorders.
Unlike SSRIs (which affect only serotonin), duloxetine's balanced inhibition of both serotonin and norepinephrine reuptake — with approximately 10:1 selectivity for serotonin — provides therapeutic benefit across a broader range of conditions including fibromyalgia, diabetic neuropathy, and musculoskeletal pain.
20 mg — delayed-release sprinkle capsule
Starting dose for patients requiring low initial dosing; also used in some pediatric dosing protocols
30 mg — delayed-release sprinkle capsule
Common starting dose for MDD and fibromyalgia titration; elderly GAD target starting dose
40 mg — delayed-release sprinkle capsule
Starting dose for MDD when 20 mg BID approach is used
60 mg — delayed-release sprinkle capsule
Most common maintenance dose for MDD, fibromyalgia, diabetic neuropathy, and chronic musculoskeletal pain
Drizalma Sprinkle can be moderately difficult to find compared to other duloxetine formulations. It is a single-source, brand-name-only product with no FDA-approved generic equivalent. Sun Pharmaceutical Industries is the sole manufacturer, meaning any production disruption directly impacts supply with no competing backup. The formal ASHP shortage that occurred in 2023–2024 has been resolved following Sun Pharma's production relaunch in mid-2024, but localized stock gaps remain common — particularly for the 20 mg and 40 mg strengths.
Not all pharmacies routinely stock Drizalma Sprinkle. Smaller independent pharmacies may not carry it at all. Even large chains may only stock certain strengths. Patients are strongly encouraged to refill early (7–10 days before running out), request 90-day supplies when possible, and check availability at multiple pharmacies. The 60 mg strength is most commonly stocked; 20 mg and 40 mg require more searching.
To find Drizalma Sprinkle at a pharmacy near you, use medfinder — medfinder calls pharmacies near you to check which ones currently have your specific medication and strength in stock, then texts you the results.
Drizalma Sprinkle (duloxetine) is not a controlled substance and has no DEA scheduling restrictions. Any licensed prescriber can write a prescription for it. The medication is available for both adults and children aged 7 and older (for generalized anxiety disorder). Typical prescriber types include:
Because duloxetine is not a controlled substance, it can be prescribed via telehealth without the restrictions that apply to controlled medications. Many telehealth platforms offer same-day or next-day visits for evaluation and prescribing of Drizalma Sprinkle when clinically appropriate.
No. Drizalma Sprinkle (duloxetine) is not a controlled substance and has no DEA schedule. This means any licensed prescriber can write a prescription without DEA registration restrictions, prescriptions can be sent electronically or by phone, and there are no federally mandated limits on the number of refills or the quantity dispensed per prescription.
Drizalma Sprinkle does require a valid prescription from a licensed healthcare provider — it is not available over the counter. But the prescribing and refilling process is simpler compared to scheduled medications. Patients can receive telehealth prescriptions for duloxetine without the restrictions that apply to controlled substances. Nurse practitioners and physician assistants can prescribe it in most states with prescriptive authority.
The most common side effects typically occur during the first 1–2 weeks and often improve as the body adjusts:
Know what you need? Skip the search.
Generic Duloxetine Delayed-Release Capsules
Same active ingredient at dramatically lower cost ($7–$20/month with coupon). Cannot be opened or sprinkled — standard capsules only. Multiple manufacturers. Best option if sprinkle formulation is not clinically required.
Venlafaxine XR (Effexor XR)
Closest SNRI alternative; FDA-approved for MDD, GAD, panic disorder, social anxiety. Extended-release capsules can be opened and contents sprinkled on applesauce. Not approved for fibromyalgia or pain. Generic available at $4–$20/month.
Milnacipran (Savella)
SNRI FDA-approved specifically for fibromyalgia. Stronger norepinephrine selectivity than duloxetine. Taken twice daily. Brand-name only; not available in sprinkle formulation. Best alternative for fibromyalgia patients.
Desvenlafaxine (Pristiq)
Active metabolite of venlafaxine; SNRI approved for MDD. Fewer drug interactions due to minimal CYP metabolism. Must be swallowed whole. Generic available at $10–$30/month. Not indicated for pain conditions.
Prefer Drizalma Sprinkle? We can find it.
MAOIs (phenelzine, selegiline, linezolid, IV methylene blue)
majorContraindicated — risk of serotonin syndrome. Do not use within 14 days of each other.
Thioridazine
majorContraindicated — duloxetine inhibits CYP2D6 metabolism of thioridazine, raising levels and causing potentially fatal arrhythmias.
Strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin)
majorSignificantly increase duloxetine plasma levels. Avoid combination.
Other serotonergic drugs (SSRIs, triptans, tramadol, St. John's Wort)
moderateIncreased risk of serotonin syndrome when combined with duloxetine.
NSAIDs and anticoagulants (warfarin, aspirin)
moderateDuloxetine affects platelet function. Combination with NSAIDs or anticoagulants increases bleeding risk.
CYP2D6 inhibitors (fluoxetine, paroxetine, bupropion)
moderateIncrease duloxetine levels by approximately 60%. May require dose adjustment.
Tricyclic antidepressants (amitriptyline, nortriptyline)
moderateDuloxetine raises TCA blood levels by inhibiting CYP2D6. Monitor TCA levels.
Alcohol
moderateSignificantly increases risk of liver damage. Avoid alcohol while taking duloxetine.
Drizalma Sprinkle fills a genuine clinical need: it's the only duloxetine formulation that can be opened and administered on food or through a feeding tube. For patients who cannot swallow standard capsules — including young children, elderly patients with dysphagia, and tube-fed patients — it provides access to duloxetine therapy that would otherwise be difficult or impossible. Its FDA approvals span depression, anxiety, diabetic neuropathy, fibromyalgia, and chronic pain, making it a versatile clinical tool.
The key challenges in 2026 are availability and cost. As a single-source brand-name product with no generic equivalent, Drizalma Sprinkle is more vulnerable to supply disruptions and more expensive than standard generic duloxetine. The formal shortage of 2023–2024 has been resolved, but patients should plan ahead, refill early, and use all available savings tools.
If you're having trouble locating Drizalma Sprinkle at a pharmacy near you, medfinder calls pharmacies near you to check which ones have your specific medication and strength in stock, then texts you the results — helping you find your prescription without making dozens of calls yourself.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards